AI assistant
Sending…
Cytosorbents Corp — Director's Dealing 2015
Jun 8, 2015
34501_dirs_2015-06-08_70b5ef1e-521d-471b-a0c0-8d17f8f740b3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2015-06-04
Reporting Person: Kraus Al (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-06-04 | Common Stock | M | 10000 | $0.875 | Acquired | 65746 | Direct |
| 2015-06-04 | Common Stock | S | 10000 | $6.30 | Disposed | 55746 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-06-04 | Stock Option | $0.875 | M | 10000 | Disposed | 2018-06-25 | Common Stock (10000) | Direct |
Footnotes
F1: Stock option exercise and open market sales pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
More from Cytosorbents Corp
Annual Report
2026
Apr 15
Regulatory Filings
2026
Apr 2
Annual Report
2026
Mar 30
Regulatory Filings
2026
Mar 25
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2025
Nov 21
Regulatory Filings
2025
Nov 13
Interim / Quarterly Report
2025
Nov 13
Regulatory Filings
2025
Oct 3
Regulatory Filings
2025
Sep 16